ЖурналыПодпискаАрхивКнигиПроектыО насРекламаДоставка/ОплатаКонтакты
+7 (495) 482-43-29
  • Главная
  • / Журналы
  • / Вернуться в журнал
  • / Содержание номера
  • / Статья
Dorsocervical fat pads: searching for effective treatment

Dorsocervical fat pads: searching for effective treatment

Authors:
Артур Халитович Исмагилов,
Андрей Ростиславович Хотян,
Виктория Владимировна Павлович,
Анна Спартаковна Ванесян,
Гитихман Тамерланович Мухамедов

Журнал: Пластическая хирургия и эстетическая медицина. 2026;(3):104-112.

DOI: 10.17116/plast.hirurgia2026031104

Read: 372 раза

Download PDF (RU)Download PDF (EN)

Abstract

OBJECTIVE

A systematic review of literature data on etiological factors and effective treatment for dorsocervical fat pad.

MATERIAL AND METHODS

A systematic review was conducted in accordance with PRISMA guidelines and included publications over the past 10 years. Only English-language studies involving adults were considered. Studies with poor design, unpublished data, case reports, experimental studies, reviews and letters to the editor were excluded. We reviewed the PubMed, Scopus, and Google Scholar databases and selected 37 studies. They covered genetic, metabolic, endocrine, infectious, and autoimmune aspects of buffalo humps, as well as their treatment including conservative and surgical approaches.

RESULTS. A

Nalysis revealed multifactorial aetiology of dorsocervical fat pad. Among non-pharmacological treatments, weight loss is effective in reducing these deposits. Injectable treatments include deoxycholic acid injections, although they are associated with side effects in early post-procedural period. Surgical methods, such as liposuction and lipectomy, are associated with high patient satisfaction. However, liposuction carries a risk of recurrence, while lipectomy negatively impacts aesthetic outcomes and can lead to seroma.

CONCLUSION

Dorsocervical fat pad requires a multidisciplinary treatment approach.

Keywords

  • dorsocervical fat pad
  • buffalo hump
  • liposuction
  • lipectomy
  • deoxycholic acid
  • lipodystrophy

Дата поступления: 29.03.2025

Дата принятия в печать: 23.06.2025

Дата публикации: 21.09.2026

References
  1. Béréziat V, Cervera P, Le Dour C, Verpont MC, Dumont S, Vantyghem MC, Capeau J, Vigouroux C; Lipodystrophy Study Group. LMNA mutations induce a non-inflammatory fibrosis and a brown fat-like dystrophy of enlarged cervical adipose tissue. Am J Pathol. 2011 Nov;179(5):2443-2453. Epub 2011 Sept 21. PMID: 21945321; PMCID: PMC3204020. https://doi.org/10.1016/j.ajpath.2011.07.049
  2. Stears A, Hames C. Diagnosis and management of lipodystrophy: a practical update. Clin Lipidol. 2014 Apr;9(2):235-259. https://doi.org/10.2217/clp.14.13
  3. Matarasso A. Liposuction as an adjunct to a full abdominoplasty revisited. Plast Reconstr Surg. 2000 Oct;106(5):1197-1202; discussion 1203-1205. PMID: 11039391. https://doi.org/10.1097/00006534-200010000-00035
  4. Nogaga V. Comparison of outcome of excision and liposuction in HIV treatment induced buffalo hump patients operated at Chris Hani Baragwanath Academic Hospital and Charlotte Maxeke Johannesburg Academic Hospital. 2021.
  5. Liu Z, Wang Y, Ma X, Zhang L, Wang C. Role of epidural fat in the local milieu: what we know and what we don’t. Connect Tissue Res. 2024; 65(2):102-116. https://doi.org/10.1080/03008207.2024.2329871
  6. Hussain I, Garg A. Lipodystrophy Syndromes. Endocrinol Metab Clin North Am. 2016 Dec;45(4):783-797. Epub 2016 Oct 06. PMID: 27823605; PMCID: PMC7590232. https://doi.org/10.1016/j.ecl.2016.06.012
  7. Lause M, Kamboj A, Fernandez Faith E. Dermatologic manifestations of endocrine disorders. Transl Pediatr. 2017 Oct;6(4):300-312. PMID: 29184811; PMCID: PMC5682371. https://doi.org/10.21037/tp.2017.09.08
  8. Mutimura E, Stewart A, Crowther NJ. Assessment of quality of life in HAART-treated HIV-positive subjects with body fat redistribution in Rwanda. AIDS Res Ther. 2007 Sept 18;4:19. PMID: 17877798; PMCID: PMC2075499. https://doi.org/10.1186/1742-6405-4-19
  9. Collins E, Wagner C, Walmsley S. Psychosocial impact of the lipodystrophy syndrome in HIV infection. AIDS Read. 2000 Sept;10(9):546-550. PMID: 11019453.
  10. Wang G, Zhao J, Zhang X, Yang S, Zhang W, Xie H. Liposuction to improve the dorsocervical fat pad in esthetic need: Anatomical study and clinical case series. J Cosmet Dermatol. 2022 Nov;21(11):5942-5951. Epub 2022 Aug 9. PMID: 35866350. https://doi.org/10.1111/jocd.15255
  11. Davis HD, Habarth-Morales TE, Messa CA IV, Broach RB, Azoury SC, Fischer JP. 81. The Impact of Body Mass Index on Surgical and Aesthetic Outcomes in Cosmetic Abdominoplasty. Plast Reconstr Surg Glob Open. 2023 May 19;11(5 Suppl):51. PMCID: PMC10194602. https://doi.org/10.1097/01.GOX.0000937916.89674.00
  12. Epstein NE, Agulnick MA. Anterior cervical surgery for morbidly obese patients should be performed in-hospitals. Surg Neurol Int. 2024 Jan 05;15:2. PMID: 38344099; PMCID: PMC10858768. https://doi.org/10.25259/SNI_957_2023
  13. Ernst G, Dalzotto P, Saban M, Ferraro FM, Salvado A, Borsini EE. The Cervical Fat Tissue Volume is a Predictor for Moderate to Severe OSA. Sleep Sci. 2023 Sept 11;16(3):e323-e328. PMID: 38196763; PMCID: PMC10773506. https://doi.org/10.1055/s-0043-1772827
  14. Pelegrini A, Sacomori C, Carmo M, Sperandio FF, Cardoso FL. Percepção da imagem corporal em mulheres: prevalência e associação com indicadores antropométricos [Body image perception in women: prevalence and association with anthropometric indicators]. Revista Brasileira de Cineantropometria e Desempenho Humano. 2013 Dec;16(1):58-65. https://doi.org/10.5007/1980-0037.2014v16n1p58
  15. Avram AS, Avram MM, James WD. Subcutaneous fat in normal and diseased states: 2. Anatomy and physiology of white and brown adipose tissue. J Am Acad Dermatol. 2005 Oct;53(4):671-683. PMID: 16198791. https://doi.org/10.1016/j.jaad.2005.05.015
  16. Okuyama C, Ushijima Y, Kubota T, et al. 123I-Metaiodobenzylguanidine uptake in the nape of the neck of children: likely visualization of brown adipose tissue. J Nucl Med. 2003;44:1421-1425.
  17. Yamamoto A, Kikuchi Y, Kusakabe T, Takano H, Sakurai K, Furui S, Oba H. Imaging spectrum of abnormal subcutaneous and visceral fat distribution. Insights Imaging. 2020 Feb 13;11(1):24. PMID: 32056035; PMCID: PMC7018866. https://doi.org/10.1186/s13244-019-0833-4
  18. Vasandani C, Li X, Sekizkardes H, Adams-Huet B, Brown RJ, Garg A. Diagnostic Value of Anthropometric Measurements for Familial Partial Lipodystrophy, Dunnigan Variety. J Clin Endocrinol Metab. 2020 July 01;105(7): 2132-2141. PMID: 32193531; PMCID: PMC7202860. https://doi.org/10.1210/clinem/dgaa137
  19. Fourman LT, Grinspoon SK. Approach to the Patient With Lipodystrophy. J Clin Endocrinol Metab. 2022 May 17;107(6):1714-1726. PMID: 35137140; PMCID: PMC9113814. https://doi.org/10.1210/clinem/dgac079
  20. Ajluni N, Meral R, Neidert AH, Brady GF, Buras E, McKenna B, DiPaola F, Chenevert TL, Horowitz JF, Buggs-Saxton C, Rupani AR, Thomas PE, Tayeh MK, Innis JW, Omary MB, Conjeevaram H, Oral EA. Spectrum of disease associated with partial lipodystrophy: lessons from a trial cohort. Clin Endocrinol (Oxf). 2017 May;86(5):698-707. Epub 2017 Mar 27. PMID: 28199729; PMCID: PMC5395301. https://doi.org/10.1111/cen.13311
  21. Patni N, Li X, Adams-Huet B, Vasandani C, Gomez-Diaz RA, Garg A. Regional Body Fat Changes and Metabolic Complications in Children With Dunnigan Lipodystrophy-Causing LMNA Variants. J Clin Endocrinol Metab. 2019 Apr 01;104(4):1099-1108. PMID: 30418556; PMCID: PMC6382455. https://doi.org/10.1210/jc.2018-01922
  22. Montenegro Jr. RM, Costa-Riquetto AD, Fernandes VO, Montenegro APDR, Santana LS, Jorge AAL, Karbage LBAS, Aguiar LB, Carvalho FHC, Teles MG, d’Alva CB. Homozygous and Heterozygous Nuclear Lamin A p.R582C Mutation: Different Lipodystrophic Phenotypes in the Same Kindred. Front Endocrinol. 2018 Aug 20;9:458. https://doi.org/10.3389/fendo.2018.00458
  23. Araújo-Vilar D, Fernández-Pombo A, Victoria B, Mosquera-Orgueira A, Cobelo-Gómez S, Castro-Pais A, Hermida-Ameijeiras Á, Loidi L, Sánchez-Iglesias S. Variable Expressivity and Allelic Heterogeneity in Type 2 Familial Partial Lipodystrophy: The p.(Thr528Met) LMNA Variant. J Clin Med. 2021 Apr 03;10(7):1497. PMID: 33916827; PMCID: PMC8038443. https://doi.org/10.3390/jcm10071497
  24. Pellegrini C, Columbaro M, Schena E, Prencipe S, Andrenacci D, Iozzo P, Angela Guzzardi M, Capanni C, Mattioli E, Loi M, Araujo-Vilar D, Squarzoni S, Cinti S, Morselli P, Giorgetti A, Zanotti L, Gambineri A, Lattanzi G. Altered adipocyte differentiation and unbalanced autophagy in type 2 Familial Partial Lipodystrophy: an in vitro and in vivo study of adipose tissue browning. Exp Mol Med. 2019 Aug 02;51(8):1-17. PMID: 31375660; PMCID: PMC6802660. https://doi.org/10.1038/s12276-019-0289-0
  25. Iwanishi M, Ito-Kobayashi J, Washiyama M, Kusakabe T, Ebihara K. Clinical Characteristics, Phenotype of Lipodystrophy and a Genetic Analysis of Six Diabetic Japanese Women with Familial Partial Lipodystrophy in a Diabetic Outpatient Clinic. Intern Med. 2018 Aug 15;57(16):2301-2313. Epub 2018 Mar 30. PMID: 29607946; PMCID: PMC6148158. https://doi.org/10.2169/internalmedicine.0225-17
  26. da Silva MA, Soares RMV, de Oliveira Filho AF, Campos LRS, de Lima JG, de Melo Campos JTA. Case report: two novel PPARG pathogenic variants associated with type 3 familial partial lipodystrophy in Brazil. Diabetol Metab Syndr. 2024 July 01;16(1):145. PMID: 38951919; PMCID: PMC11218129. https://doi.org/10.1186/s13098-024-01387-9
  27. Zolotov S, Xing C, Mahamid R, Shalata A, Sheikh-Ahmad M, Garg A. Homozygous LIPE mutation in siblings with multiple symmetric lipomatosis, partial lipodystrophy, and myopathy. Am J Med Genet A. 2017 Jan;173(1):190-194. Epub 2016 Nov 11. PMID: 27862896; PMCID: PMC5788284. https://doi.org/10.1002/ajmg.a.37880
  28. Rocha N, Bulger DA, Frontini A, Titheradge H, Gribsholt SB, Knox R, Page M, Harris J, Payne F, Adams C, Sleigh A, Crawford J, Gjesing AP, Bork-Jensen J, Pedersen O, Barroso I, Hansen T, Cox H, Reilly M, Rossor A, Brown RJ, Taylor SI, McHale D, Armstrong M, Oral EA, Saudek V, O’Rahilly S, Maher ER, Richelsen B, Savage DB, Semple RK. Human biallelic MFN2 mutations induce mitochondrial dysfunction, upper body adipose hyperplasia, and suppression of leptin expression. Elife. 2017 Apr 19; 6:e23813. PMID: 28414270; PMCID: PMC5422073. https://doi.org/10.7554/eLife.23813
  29. Vigouroux C, Magré J, Vantyghem MC, Bourut C, Lascols O, Shackleton S, Lloyd DJ, Guerci B, Padova G, Valensi P, Grimaldi A, Piquemal R, Touraine P, Trembath RC, Capeau J. Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy. Diabetes. 2000 Nov;49(11):1958-1962. PMID: 11078466. https://doi.org/10.2337/diabetes.49.11.1958
  30. Hundeshagen G, Hundeshagen G, Assadov KF, Podmelle F. Facelift- and circum-occipital incision placement for fat extirpation of the neck in Madelung’s disease — a two-case report. J Craniomaxillofac Surg. 2014 Mar; 42(2):175-179. Epub 2013 June 10. PMID: 23757287. https://doi.org/10.1016/j.jcms.2013.04.011
  31. Ma Y, Guo Z, Wang L, Wang Q, Cheng X, Yan D. Assessment of 3.0 Tesla magnetic resonance imaging in Madelung’s deformity: findings and implications. BMC Musculoskelet Disord. 2024 Feb 12;25(1):133. PMID: 38347477; PMCID: PMC10860302. https://doi.org/10.1186/s12891-024-07245-z
  32. Tsaban G, Bilitzky-Kopit A, Yaskolka Meir A, Zelicha H, Gepner Y, Shelef I, Orr O, Chassidim Y, Sarusi B, Ceglarek U, Stumvoll M, Blüher M, Stampfer MJ, Shai I, Schwarzfuchs D. The Effect of Weight-Loss Interventions on Cervical and Chin Subcutaneous Fat Depots; the CENTRAL Randomized Controlled Trial. Nutrients. 2021 Oct 27;13(11):3827. PMID: 34836081; PMCID: PMC8617936. https://doi.org/10.3390/nu13113827
  33. Gallagher D, Heshka S, Kelley DE, Thornton J, Boxt L, Pi-Sunyer FX, Patricio J, Mancino J, Clark JM; MRI Ancillary Study Group of Look AHEAD Research Group. Changes in adipose tissue depots and metabolic markers following a 1-year diet and exercise intervention in overweight and obese patients with type 2 diabetes. Diabetes Care. 2014 Dec;37(12):3325-3332. Epub 2014 Oct 21. PMID: 25336745; PMCID: PMC4237982. https://doi.org/10.2337/dc14-1585
  34. Linder K, Springer F, Machann J, Schick F, Fritsche A, Häring HU, Blumenstock G, Ranke MB, Stefan N, Binder G, Ehehalt S. Relationships of body composition and liver fat content with insulin resistance in obesity-matched adolescents and adults. Obesity (Silver Spring). 2014 May;22(5): 1325-1331. Epub 2014 Mar 19. PMID: 24375954. https://doi.org/10.1002/oby.20685
  35. Javorsky BR, Carroll TB, Tritos NA, Salvatori R, Heaney AP, Fleseriu M, Biller BM, Findling JW. Discovery of Cushing’s Syndrome After Bariatric Surgery: Multicenter Series of 16 Patients. Obes Surg. 2015 Dec;25(12):2306-2313. PMID: 25917980. https://doi.org/10.1007/s11695-015-1681-z
  36. Mukherjee S, Samajdar SS, Tripathi SK. Glucocorticoids and Cushing Syndrome: A Tale of Three Cases. Asian Journal of Pharmaceutical and Health Sciences. Jan-Mar 2019;9(1):2032-2034.
  37. Adachi M, Oto Y, Muroya K, Hanakawa J, Asakura Y, Goto H. Partial lipodystrophy in patients who have undergone hematopoietic stem cell transplantation during childhood: an institutional cross-sectional survey. Clin Pediatr Endocrinol. 2017;26(2):99-108. Epub 2017 Apr 22. PMID: 28458462; PMCID: PMC5402311. https://doi.org/10.1297/cpe.26.99
  38. Sorkina E, Frolova E, Rusinova D, Polyakova S, Roslavtseva E, Vasilyev E, Petrov V, Tiulpakov A. Progressive Generalized Lipodystrophy as a Manifestation of Autoimmune Polyglandular Syndrome Type 1. J Clin Endocrinol Metab. 2016 Apr 01;101(4):1344-1347. https://doi.org/10.1210/jc.2015-3722
  39. Sánchez P, Infante A, de Eguino GR, Fuentes-Maestre JA, García-Verdugo JM, Rodríguez CI. Age-Related Lipid Metabolic Signature in Human LMNA-Lipodystrophic Stem Cell-Derived Adipocytes. J Clin Endocrinol Metab. 2015 July;100(7):E964-E973. Epub 2015 May 11. PMID: 25961135. https://doi.org/10.1210/jc.2014-4528
  40. Fernandez-Pombo A, Diaz-Lopez EJ, Castro AI, Sanchez-Iglesias S, Cobelo-Gomez S, Prado-Moraña T, Araujo-Vilar D. Clinical Spectrum of LMNA-Associated Type 2 Familial Partial Lipodystrophy: A Systematic Review. Cells. 2023 Feb 24;12(5):725. PMID: 36899861; PMCID: PMC10000975. https://doi.org/10.3390/cells12050725
  41. Akinci B, Koseoglu FD, Onay H, Yavuz S, Altay C, Simsir IY, Ozisik S, Demir L, Korkut M, Yilmaz N, Ozen S, Akinci G, Atik T, Calan M, Secil M, Comlekci A, Demir T. Acquired partial lipodystrophy is associated with increased risk for developing metabolic abnormalities. Metabolism: Clinical and Experimental. 2015 Sept;64(9):1086-1095. Epub 2015 Jun 10. PMID: 26139569. https://doi.org/10.1016/j.metabol.2015.06.004
  42. Payne F, Lim K, Girousse A, Brown RJ, Kory N, Robbins A, Xue Y, Sleigh A, Cochran E, Adams C, Dev Borman A, Russel-Jones D, Gorden P, Semple RK, Saudek V, O’Rahilly S, Walther TC, Barroso I, Savage DB. Mutations disrupting the Kennedy phosphatidylcholine pathway in humans with congenital lipodystrophy and fatty liver disease. Proc Natl Acad Sci. June 2014;111(24):8901-8906. https://doi.org/10.1073/pnas.1408523111
  43. Rittes PG. The use of phosphatidylcholine for correction of lower lid bulging due to prominent fat pads. Dermatol Surg. 2001 Apr;27(4):391-392. PMID: 11298713. https://doi.org/10.1046/j.1524-4725.2001.00282.x
  44. Rotunda AM, Suzuki H, Moy RL, Kolodney MS. Detergent Effects of Sodium Deoxycholate Are a Major Feature of an Injectable Phosphatidylcholine Formulation Used for Localized Fat Dissolution. Dermatol Surg. July 2004;30(7):1001. https://doi.org/10.1111/j.1524-4725.2004.30305.x
  45. Kulkarni V, Salunke TS, Mandhane AG, Vaidya P. Use of Intralesional Deoxycholic Acid for Antiretroviral Treatment Associated Lipohypertrophy: A Qualitative Open-Label Study of an Innovative Indication. J Cutan Aesthet Surg. 2023 Apr-June;16(2):134-139. PMID: 37554685; PMCID: PMC10405548. https://doi.org/10.4103/JCAS.JCAS_150_22
  46. Chirico F, Rauso GM, Fragola R, Lo Giudice G, Pinto L, De Falco N, Cosenza A, Rugge L, Sgaramella N, Tartaro G. Complications Following Non-Surgical Aesthetic Treatments in HIV+ Patients Receiving Antiretroviral Therapy: A 12-Years Experience. Applied Sciences. 2021 Apr 29;11(9): 4059. https://doi.org/10.3390/app11094059
  47. Rauso R, Zerbinati N, Giudice GL, Fragola R, Bove P, Nicoletti GF. Safety and tolerability of deoxycholic acid injections in head and neck areas. Aesthetic Medicine Journal. 2021;41:11.
  48. Wall SH Jr, Lee MR. Separation, Aspiration, and Fat Equalization: SAFE Liposuction Concepts for Comprehensive Body Contouring. Plastic and Reconstructive Surgery. 2016 Dec;138(6):1192-1201. https://doi.org/10.1097/PRS.0000000000002808
  49. Finkelstein JL, Gala P, Rochford R, Glesby MJ, Mehta S. HIV/AIDS and lipodystrophy: implications for clinical management in resource-limited settings. J Int AIDS Soc. 2015 Jan 15;18(1):19033. PMID: 25598476; PMCID: PMC4297925. https://doi.org/10.7448/IAS.18.1.19033
  50. Matarasso SL. Liposuction of the chest and back. Dermatol Clin. 1999 Oct; 17(4):799-804, vi. PMID: 10526711. https://doi.org/10.1016/s0733-8635(05)70128-5
  51. Barton N, Moore R, Prasad K, Evans G. Excisional lipectomy versus liposuction in HIV-associated lipodystrophy. Arch Plast Surg. 2021 Nov;48(6):685-690. Epub 2021 Nov 15. PMID: 34818717; PMCID: PMC8627937. https://doi.org/10.5999/aps.2020.02285
  52. Chen S, Gui X-E, Cao Q, Routy J-P. Clinical outcome after lipectomy in the management of patients with human immunodeficiency virus-associated dorsocervical fat accumulation: An observational cohort study. Medicine (Baltimore). 2019 June;98(25):e16112. PMID: 31232958; PMCID: PMC6636914. https://doi.org/10.1097/MD.0000000000016112
slide-cover
slide-cover
slide-cover

Recommended articles:

Abdominoplasty without scars in umbilical area.Plastic Surgery and Aesthetic Medicine. 2026;(3):26-34

TECAR therapy for complications after brachioplasty.Plastic Surgery and Aesthetic Medicine. 2026;(2):62-67

S.A.F.E. Score 2.0 — evolution of integral surgical risk stratification scale in aesthetic plastic surgery.Plastic Surgery and Aesthetic Medicine. 2026;(2-2):51-57

Results of various brachioplasty options after massive weight loss.Plastic Surgery and Aesthetic Medicine. 2026;(1):49-55

Vibration amplification of sound energy at resonance (VASER): guidelines based on consensus of experts.Plastic Surgery and Aesthetic Medicine. 2025;(4):5-12

New technique for tissue stabilization in lower body lift.Plastic Surgery and Aesthetic Medicine. 2025;(3-2):34-41

Liposuction and abdominoplasty in body contouring: synergy or antagonism?Plastic Surgery and Aesthetic Medicine. 2025;(3):71-78

A modern view on the problem of complications after brachioplasty.Plastic Surgery and Aesthetic Medicine. 2025;(2-2):91-95

Modern approaches for abdominoplasty.Plastic Surgery and Aesthetic Medicine. 2025;(2):109-116

CCL method in lower limb contouring.Plastic Surgery and Aesthetic Medicine. 2024;(4):39-45

Издательство «Медиа Сфера»
РекламаДоставка/ОплатаО насКонтактыОбучение для редакцийПолитика конфиденциальностиПолитика обработки персональных данныхПубличная оферта на реализацию издательской продукции
ЖурналыПодпискаАрхивКнигиПроекты
  • RuStore

© 1998-2026

  • Телефоны издательства:

  • +7 (495) 482-41-18
  • +7 (495) 482-43-29

  • Прямой телефон отдела подписки
    (только по вопросам заказов и доставки журналов)

  • +7 (800) 250-18-12

  • пн-пт с 10:00 до 18:00

  • Telegram
  • VK
info@mediasphera.ru

  • Почтовый адрес:

  • Издательство «Медиа Сфера»,
    а/я 54, Москва, Россия, 127238

  • RuStore

© 1998-2026